Search results
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 8 hours agoHowever, chronic care enrollment was up 9% year over year. And even though the company is still...
Wegovy could bankrupt US health system, Sanders says in new report
The Hill via Yahoo News· 1 day agoBlockbuster weight-loss drug Wegovy could bankrupt the U.S. health care system unless the price...
Earnings call: OMNIQ reports revenue growth and fintech expansion By Investing.com
Investing.com· 4 hours ago:OMQS) has announced a positive start to the year in their First Quarter 2024 Earnings Conference...
China-connected South Bay biotech company called out by Congress in Biosecure Act - San Francisco...
The Business Journals· 23 hours agoA San Jose biotech company owned by a Chinese company is at the center of a U.S.-China tug-of-war...
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 7 days ago“These are drugs we’ve used forever.” But what causes shortages? And more to the point, what do you...
Earnings call: Panbela Therapeutics reports on ASPIRE trial progress By Investing.com
Investing.com· 9 hours agoThe trial, which is evaluating the drug ivospemin in combination with other treatments for...
Biogen, Ionis shelve ALS drug following study failure
BioPharma Dive via Yahoo Finance· 9 hours agoWhile results indicated the drug works as intended, it didn’t have enough of an effect on a protein...
President Biden announces moves to relax weed restrictions
Politico via Yahoo News· 1 hour agoBiden on Thursday announced the DOJ would reclassify cannabis to a less restrictive category on the Controlled Substances Act, the biggest change in federal drug law in decades.
Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling
Zacks via Yahoo Finance· 4 hours agoShares of the company have gained 21.6% compared with the industry’s growth of 31.8% Image Source:...
FTC warns pharma companies it means business with its Orange Book listing policy | JD Supra
JD Supra· 2 days agoLast September, the Federal Trade Commission (FTC) promulgated a “policy statement” entitled “Statement Concerning Brand Drug Manufacturers’ Improper Listing of Patents in ...